Treatment type: Immunotherapies

  • Searching for clues to how RNA triggers the immune system

    A young Melbourne scientist will spend the next three years advancing exiting new mRNA research to unlock the secrets to how RNA triggers the immune system to fight infection.…  Read more

    Dr Natália Sampaio from the Regulation of Interferon and Innate Signalling Research Group

  • Hudson Institute welcomes childhood cancer pledge

    As a global leader in the field of childhood cancer research, Hudson Institute of Medical Research welcomes the Victorian Government’s pledge to invest $35 million in this area of vital need.…  Read more

    Children like Lachy and their families will benefit from VPCC's childhood cancer research.

  • Big step toward slowing emphysema

    Researchers are closer than ever to being able to turn off the actions of the immune system that damage the lungs – opening up the possibility of slowing emphysema development.…  Read more

    Professor Brendan Jenkins works on being able to turn off the actions of the immune system that damage the lungs, opening up the possibility of slowing emphysema development.

  • US Defense Dept backs Aussie upper gastrointestinal cancer research

    If an army marches on its stomach, as the old saying goes, then the US Department of Defense (DoD) is investing wisely in Australian upper gastrointestinal cancer research.…  Read more

    Professor Brendan Jenkins receives funding from the US Defense Department to work on upper gastrointestinal cancer research.

  • Victorian government funding boost for new anti-inflammatory treatments

    Hudson Institute’s groundbreaking research into new anti-inflammatory treatments has attracted the support of the Victorian government, in recognition of its potential to treat COVID-19 and other infectious diseases.…  Read more

    Associate Professor Michael Gantier's groundbreaking research into inflammation has attracted funding support from the Victorian government to assist with new anti-inflammatory treatments.

  • RNA boost for autoimmune disease

    The enormous potential of RNA-based treatments for autoimmune diseases has been recognised by the Victorian government, with a new grant from the mRNA Victoria Research Acceleration Fund.…  Read more

    Associate Professor Michael Gantier has been awarded a new grant to research further into RNA-based treatments for autoimmune diseases.

  • Flicking the inflammation off-switch

    Many human diseases, including autoimmune diseases such as arthritis or inflammatory bowel disease, are characterised by too much inflammation.
    There has been a gap in producing new generations of potent anti-inflammatory therapeutics for these anti-inflammatory conditions.…  Read more

    A/Prof Claudia Nold and Professor Marcel Nold from The Ritchie Centre at Hudson Institute of Medical Research

  • Silicosis research awarded more than $1.6 million

    Hudson Institute of Medical Research and Monash University have received more than $1.6 million in funding from the Federal Government’s Medical Research Future Fund (MRFF) towards research investigating ways to prevent and treat silicosis.…  Read more

    Inflammation scientists Associate Professor Michelle Tate and Associate Professor Ashley Mansell

  • Ovarian cancer treatment hope

    Hudson Institute researchers have shown for the first time that a diabetes drug called sitagliptin can limit tumour growth, and possibly extend survival rates from epithelial ovarian cancer, the most common and dangerous type of ovarian cancer.…  Read more

    Scientist, Dr Amy Wilson at Hudson Institute

  • NHMRC Ideas Grants success

    Hudson Institute has been successful in the NHMRC Ideas Grant round. Our researchers have been awarded four NHMRC Ideas Grants, totalling almost $4.1 million.…  Read more

    Sam, Paul, Ed and Vince, Hudson Institute's successful NHMRC Ideas Grants recipients